Recent Courses

Title Credit Start and expiration datessort descending Member price Non-member price
2017 Pediatric RX, Module 5: Nutraceutical and Supplement Use in Children
  • 1.00 Contact hours
10/01/2017 to 09/30/2019 $10.00 $20.00
2017 Pediatric RX, Module 1: What's New in Pediatric Pharmacology
  • 1.25 Contact hours
10/01/2017 to 09/30/2019 $12.00 $25.00
2017 Pediatric Rx, Module 4- GI Drugs
  • 0.50 Contact hours
10/01/2017 to 09/30/2019 $5.00 $10.00
2017 Pediatric Rx, Module 2- Respiratory Drugs
  • 1.25 Contact hours
10/01/2017 to 09/30/2019 $12.00 $25.00
Food Protein-Induced Enterocolitis Syndrome (FPIES)
  • 1.00 Contact hours
10/17/2018 to 10/31/2019 $10.00 $20.00

Pages

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.

More NAPNAP CE Courses!

PedsCESM News: 

Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention - Medscape Education and NAPNAP

NAPNAP’s newest online CE course, Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention, features two of our members Deena Garner, DNP, APRN CPNP-PC and Alison Moriarty Daley, PhD, APRN, PPCNP-BC, FAAN, and will improve clinicians' knowledge and competence regarding human papillomavirus (HPV) vaccination recommendations and strategies for advocating for vaccination and improving vaccine uptake. This FREE CE activity offers 0.5 NAPNAP contact hours (0.5 Rx) and is available now!

Clinical Insights in Pediatrics: Juvenile Idiopathic Arthritis: Diagnosis and Management in Primary Care - cmecorner.com

This activity offered by cmecorner.com discusses the most common inflammatory arthritis in the pediatric population. Over 300,000 children and adolescents are affected by JIA in the USA.The management of JIA represents a significant challenge to physicians, NPs, and other clinicians, particularly those in front-line specialties such as pediatrics and primary care. This activity will address timely diagnosis/classification of JIA and appropriate treatment, which are critical for preventing joint damage and improving long-term outcomes. Approved for 0.75 NAPNAP Contact Hour of which 0.25 contain pharmacology content. (Expires September 14, 2019).